MicroRNAs in B cell development and malignancy

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Fernando, Thilini R ^a   Rodriguez Malave, Norma I ^a,b   Rao, Dinesh S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BRUTON TYROSINE KINASE; EXPORTIN 5; INTERLEUKIN 7; MICRORNA; PROTEIN BCL 2; RNA POLYMERASE II; STAT5 PROTEIN; TRANSCRIPTION FACTOR PAX5; X BOX BINDING PROTEIN 1;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BIOGENESIS; BONE MARROW; CAENORHABDITIS ELEGANS; CELL MATURATION; CELL PROLIFERATION; CHROMOSOME 13; CHROMOSOME TRANSLOCATION; DNA DAMAGE; DNA SEQUENCE; GENE DELETION; GENE REGULATORY NETWORK; HEMATOLOGIC MALIGNANCY; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; LYMPHATIC LEUKEMIA; LYMPHOID PROGENITOR CELL; LYMPHOPOIESIS; NONHODGKIN LYMPHOMA; NONHUMAN; REVIEW; RHEUMATIC DISEASE; RNA TRANSCRIPTION; STATISTICAL ANALYSIS; STEM CELL; ANIMAL; BIOLOGICAL MODEL; BLOOD DISEASE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL;

EID: 84857934694     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-7     Document Type: Review

References (123)

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC, Nature 1998 391 806 811 10.1038/35888 9486653 (Pubitemid 28099681)
2. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Lee RC, Feinbaum RL, Ambros V, Cell 1993 75 843 854 10.1016/0092-8674(93)90529-Y 8252621 (Pubitemid 24014542)
3. The Caenorhabditis elegans heterochronic gene lin-14 encodes a nuclear protein that forms a temporal developmental switch. Ruvkun G, Giusto J, Nature 1989 338 313 319 10.1038/338313a0 2922060
4. Role for a bidentate ribonuclease in the initiation step of RNA interference. Bernstein E, Caudy AA, Hammond SM, Hannon GJ, Nature 2001 409 363 366 10.1038/35053110 11201747 (Pubitemid 32151243)
5. Argonaute2, a link between genetic and biochemical analyses of RNAi. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ, Science (New York, NY 2001 293 1146 1150 10.1126/science.1064023 (Pubitemid 32758097)
6. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH, Genes Dev 2001 15 2654 2659 10.1101/gad.927801 11641272 (Pubitemid 32988876)
7. MicroRNAs and other tiny endogenous RNAs in C. elegans. Ambros V, Lee RC, Lavanway A, Williams PT, Jewell D, Curr Biol 2003 13 807 818 10.1016/S0960-9822(03)00287-2 12747828 (Pubitemid 36573248)
8. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Wightman B, Ha I, Ruvkun G, Cell 1993 75 855 862 10.1016/0092-8674(93)90530-4 8252622 (Pubitemid 24014543)
9. Biogenesis of small RNAs in animals. Kim VN, Han J, Siomi MC, Nat Rev Mol Cell Biol 2009 10 126 139 10.1038/nrm2632 19165215
10. MicroRNA genes are transcribed by RNA polymerase II. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN, EMBO J 2004 23 4051 4060 10.1038/sj.emboj. 7600385 15372072 (Pubitemid 39472426)
11. The nuclear RNase III Drosha initiates microRNA processing. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN, Nature 2003 425 415 419 10.1038/nature01957 14508493 (Pubitemid 37187272)
12. The Microprocessor complex mediates the genesis of microRNAs. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R, Nature 2004 432 235 10.1038/nature03120 15531877 (Pubitemid 39545855)
13. Nuclear export of microRNA precursors. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U, Science (New York, NY 2004 303 95 98 10.1126/science. 1090599 (Pubitemid 38055779)
14. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 215 233 10.1016/j.cell.2009.01.002 19167326
15. MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP, Mol Cell 2007 27 91 105 10.1016/j.molcel.2007.06.017 17612493 (Pubitemid 46991392)
16. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Lewis BP, Burge CB, Bartel DP, Cell 2005 120 15 20 10.1016/j.cell.2004.12.035 15652477 (Pubitemid 40094598)
17. Principles of microRNA-target recognition. Brennecke J, Stark A, Russell RB, Cohen SM, PLoS biology 2005 3 85 10.1371/journal.pbio.0030085 15723116 (Pubitemid 40605291)
18. Small RNA sorting: matchmaking for Argonautes. Czech B, Hannon GJ, Nat Rev Genet 2011 12 19 31 21116305
19. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, Cheloufi S, Ma E, Mane S, Hannon GJ, Lawson ND, et al. Science (New York, NY 2010 328 1694 1698 10.1126/science.1190809
20. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Carmell MA, Xuan Z, Zhang MQ, Hannon GJ, Genes Dev 2002 16 2733 2742 10.1101/gad.1026102 12414724 (Pubitemid 35253139)
21. Identification of eight members of the Argonaute family in the human genome small star, filled. Sasaki T, Shiohama A, Minoshima S, Shimizu N, Genomics 2003 82 323 330 10.1016/S0888-7543(03)00129-0 12906857 (Pubitemid 36957926)
22. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Xu S, Guo K, Zeng Q, Huo J, Lam KP, Blood 2012 119 767 776 10.1182/blood-2011-05-355412 22117047
23. MicroRNAs prevent the generation of autoreactive antibodies. Belver L, de Yebenes VG, Ramiro AR, Immunity 2010 33 713 722 10.1016/j.immuni.2010.11.010 21093320
24. Role of microRNAs in lymphoid biology and disease. Fabbri M, Croce CM, Current Opinion in Hematology 2011 18 266 272 10.1097/MOH.0b013e3283476012 21519241
25. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM, Immunity 2002 17 51 62 10.1016/S1074-7613(02)00335-7 12150891 (Pubitemid 34874618)
26. B cell development pathways. Hardy RR, Hayakawa K, Annu Rev Immunol 2001 19 595 621 10.1146/annurev.immunol.19.1.595 11244048 (Pubitemid 32368047)
27. Signaling proteins and transcription factors in normal and malignant early B cell development. Perez-Vera P, Reyes-Leon A, Fuentes-Panana EM, Bone marrow research 2011 2011 502751 22046564
28. MicroRNAs: new regulators of immune cell development and function. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD, Nature immunology 2008 9 839 845 10.1038/ni.f.209 18645592 (Pubitemid 352038302)
29. Microenvironmental niches in the bone marrow required for B-cell development. Nagasawa T, Nature reviews Immunology 2006 6 107 116 10.1038/nri1780 16491135 (Pubitemid 43361586)
30. The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease. Arawaka S, Wada M, Goto S, Karube H, Sakamoto M, Ren CH, Koyama S, Nagasawa H, Kimura H, Kawanami T, et al. The Journal of neuroscience: the official journal of the Society for Neuroscience 2006 26 9227 9238 10.1523/JNEUROSCI.0341-06.2006 (Pubitemid 44359849)
31. Human trials of malaria vaccine. Nussenweig RS, Science (New York, NY 1987 236 763
32. Janeway's Immunobiology. Murphy K, Book Janeway's Immunobiology City: Garland Science, Taylor & Francis Group, LLC 8 2012 8895032
33. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Nemazee D, Buerki K, Proc Natl Acad Sci USA 1989 86 8039 8043 10.1073/pnas.86.20.8039 2682636 (Pubitemid 19265315)
34. The transcriptional regulation of B cell lineage commitment. Nutt SL, Kee BL, Immunity 2007 26 715 725 10.1016/j.immuni.2007.05.010 17582344 (Pubitemid 46908962)
35. Foxp1 is an essential transcriptional regulator of B cell development. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW, Rao A, Nature immunology 2006 7 819 826 10.1038/ni1358 16819554 (Pubitemid 44084088)
36. Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birth. Kikuchi K, Kondo M, Proc Natl Acad Sci USA 2006 103 17852 17857 10.1073/pnas.0603368103 17090683 (Pubitemid 44852249)
37. Stat5a/b are essential for normal lymphoid development and differentiation. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, Hissong BD, Li D, Durum SK, Jiang Q, Bhandoola A, et al. Proc Natl Acad Sci USA 2006 103 1000 1005 10.1073/pnas.0507350103 16418296 (Pubitemid 43212211)
38. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, Cui Y, Beug H, Hennighausen L, Moriggl R, Sexl V, Blood 2006 107 4898 4906 10.1182/blood-2005-09-3596 16493008 (Pubitemid 43882643)
39. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, et al. Cell 1994 79 885 892 10.1016/0092-8674(94)90077-9 8001125 (Pubitemid 24371978)
40. Pax5: the guardian of B cell identity and function. Cobaleda C, Schebesta A, Delogu A, Busslinger M, Nature immunology 2007 8 463 470 10.1038/ni1454 17440452 (Pubitemid 46605911)
41. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J, et al. Nature immunology 2010 11 635 643 10.1038/ni.1891 20543837
42. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. O'Riordan M, Grosschedl R, Immunity 1999 11 21 31 10.1016/S1074-7613(00)80078-3 10435576 (Pubitemid 29359954)
43. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D, Immunity 2010 33 48 59 10.1016/j.immuni.2010.06.013 20598588
44. Oncogenic transcription factors in the human acute leukemias. Look AT, Science 1997 278 1059 1064 10.1126/science.278.5340.1059 9353180 (Pubitemid 27517875)
45. The roles of transcription factors in B lymphocyte commitment, development, and transformation. Smith E, Sigvardsson M, J Leukoc Biol 2004 75 973 981 10.1189/jlb.1103554 14982952 (Pubitemid 38720637)
46. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, et al. Nature 2007 446 758 764 10.1038/nature05690 17344859 (Pubitemid 46582031)
47. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Familiades J, Bousquet M, Lafage-Pochitaloff M, Bene MC, Beldjord K, De Vos J, Dastugue N, Coyaud E, Struski S, Quelen C, et al. Leukemia 2009 23 1989 1998 10.1038/leu.2009.135 19587702
48. High-risk childhood acute lymphoblastic leukemia. Bhojwani D, Howard SC, Pui CH, Clin Lymphoma Myeloma 2009 9 Suppl 3 222 230 19778845
49. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, et al. Nature 2008 453 110 114 10.1038/nature06866 18408710 (Pubitemid 351630327)
50. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Sun L, Heerema N, Crotty L, Wu X, Navara C, Vassilev A, Sensel M, Reaman GH, Uckun FM, Proc Natl Acad Sci USA 1999 96 680 685 10.1073/pnas.96.2.680 9892693 (Pubitemid 29061268)
51. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Nakase K, Ishimaru F, Avitahl N, Dansako H, Matsuo K, Fujii K, Sezaki N, Nakayama H, Yano T, Fukuda S, et al. Cancer Res 2000 60 4062 4065 10945610 (Pubitemid 30636585)
52. Detection of different Ikaros isoforms in human leukaemias using real-time quantitative polymerase chain reaction. Olivero S, Maroc C, Beillard E, Gabert J, Nietfeld W, Chabannon C, Tonnelle C, Br J Haematol 2000 110 826 830 10.1046/j.1365-2141.2000.02297.x 11054064
53. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia. Nishii K, Katayama N, Miwa H, Shikami M, Usui E, Masuya M, Araki H, Lorenzo F, Ogawa T, Kyo T, et al. Leukemia 2002 16 1285 1292 10.1038/sj.leu.2402533 12094252
54. Expression of the Ikaros gene family in childhood acute lymphoblastic leukaemia. Takanashi M, Yagi T, Imamura T, Tabata Y, Morimoto A, Hibi S, Ishii E, Imashuku S, Br J Haematol 2002 117 525 530 10.1046/j.1365-2141.2002.03487.x 12028018 (Pubitemid 34539224)
55. Relative expression of different Ikaros isoforms in childhood acute leukemia. Meleshko AN, Movchan LV, Belevtsev MV, Savitskaja TV, Blood Cells Mol Dis 2008 41 278 283 10.1016/j.bcmd.2008.06.006 18675565
56. Global genomic characterization of acute lymphoblastic leukemia. Mullighan CG, Downing JR, Semin Hematol 2009 46 3 15 10.1053/j.seminhematol. 2008.09.005 19100363
57. The Ikaros gene is required for the development of all lymphoid lineages. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A, Cell 1994 79 143 156 10.1016/0092-8674(94)90407-3 7923373 (Pubitemid 24309520)
58. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, Gonzales E, Wu P, Neben S, Georgopoulos K, EMBO J 1997 16 2004 2013 10.1093/emboj/16.8.2004 9155026 (Pubitemid 27170961)
59. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A, Leukemia 2005 19 652 658 15703784 (Pubitemid 40521171)
60. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Wlodarska I, Veyt E, De Paepe P, Vandenberghe P, Nooijen P, Theate I, Michaux L, Sagaert X, Marynen P, Hagemeijer A, De Wolf-Peeters C, Leukemia 2005 19 1299 1305 10.1038/sj.leu.2403813 15944719 (Pubitemid 41136318)
61. B-1 B cell development in the fetus and adult. Montecino-Rodriguez E, Dorshkind K, Immunity 2012 36 13 21 10.1016/j.immuni.2011.11.017 22284417
62. Regulation of plasma-cell development. Shapiro-Shelef M, Calame K, Nature reviews Immunology 2005 5 230 242 10.1038/nri1572 15738953 (Pubitemid 40364824)
63. Transcriptional analysis of the B cell germinal center reaction. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad J Jr, Miljkovic V, Cattoretti G, Califano A, Dalla-Favera R, Proc Natl Acad Sci USA 2003 100 2639 2644 10.1073/pnas.0437996100 12604779 (Pubitemid 36297551)
64. Targeting of somatic hypermutation. Odegard VH, Schatz DG, Nature reviews Immunology 2006 6 573 583 10.1038/nri1896 16868548 (Pubitemid 44134090)
65. Antigen-specific memory B cell development. McHeyzer-Williams LJ, McHeyzer-Williams MG, Annu Rev Immunol 2005 23 487 513 10.1146/annurev.immunol. 23.021704.115732 15771579 (Pubitemid 40563178)
66. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, Dalla-Favera R, Nature immunology 2006 7 773 782 10.1038/ni1357 16767092 (Pubitemid 43905877)
67. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Cambier JC, Gauld SB, Merrell KT, Vilen BJ, Nat Rev Immunol 2007 7 633 643 10.1038/nri2133 17641666 (Pubitemid 47123549)
68. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Bartel DP, Chen CZ, Nat Rev Genet 2004 5 396 400 15143321 (Pubitemid 38529411)
69. MicroRNAs modulate hematopoietic lineage differentiation. Chen CZ, Li L, Lodish HF, Bartel DP, Science (New York, NY 2004 303 83 86 10.1126/science. 1091903 (Pubitemid 38055775)
70. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, Jensen K, Cobb BS, Merkenschlager M, Rajewsky N, Rajewsky K, Cell 2008 132 860 874 10.1016/j.cell.2008.02.020 18329371 (Pubitemid 351312808)
71. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K, Nature immunology 2008 9 405 414 10.1038/ni1575 18327259 (Pubitemid 351405110)
72. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K, Cell 2007 131 146 159 10.1016/j.cell.2007.07. 021 17923094 (Pubitemid 47498525)
73. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF, Proc Natl Acad Sci USA 2007 104 7080 7085 10.1073/pnas.0702409104 17438277 (Pubitemid 47186012)
74. MicroRNA control in the immune system: basic principles. Xiao C, Rajewsky K, Cell 2009 136 26 36 10.1016/j.cell.2008.12.027 19135886
75. Antibody regulation of B cell development. Meffre E, Casellas R, Nussenzweig MC, Nature immunology 2000 1 379 385 10.1038/80816 11062496
76. A microRNA component of the p53 tumour suppressor network. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. Nature 2007 447 1130 1134 10.1038/nature05939 17554337 (Pubitemid 47014436)
77. Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis. Chang T-C, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee Kwang H, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Molecular Cell 2007 26 745 752 10.1016/j.molcel.2007.05.010 17540599 (Pubitemid 46856245)
78. p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al. Curr Biol 2007 17 1298 1307 10.1016/j.cub.2007.06. 068 17656095 (Pubitemid 47176893)
79. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, Baltimore D, Proc Natl Acad Sci USA 2010 107 14235 14240 10.1073/pnas.1009798107 20660734
80. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI, Proc Natl Acad Sci USA 2007 104 2750 2755 10.1073/pnas.0610983104 17293455 (Pubitemid 46327951)
81. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Moller P, Poppema S, Kroesen BJ, van den Berg A, Neoplasia (New York, NY 2009 11 167 176
82. MicroRNA-155 is induced during the macrophage inflammatory response. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, Proc Natl Acad Sci USA 2007 104 1604 1609 10.1073/pnas.0610731104 17242365 (Pubitemid 46214637)
83. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Taganov KD, Boldin MP, Chang KJ, Baltimore D, Proc Natl Acad Sci USA 2006 103 12481 12486 10.1073/pnas.0605298103 16885212 (Pubitemid 44267285)
84. Requirement of bic/microRNA-155 for normal immune function. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, et al. Science (New York, NY 2007 316 608 611 10.1126/science.1139253 (Pubitemid 46683148)
85. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, et al. Immunity 2007 27 847 859 10.1016/j.immuni.2007.10.009 18055230 (Pubitemid 350258623)
86. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R, Papavasiliou FN, Immunity 2008 28 621 629 10.1016/j.immuni.2008.03.015 18450484
87. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF, Di Virgilio M, San-Martin BR, Heidkamp G, Schwickert TA, et al. Immunity 2008 28 630 638 10.1016/j.immuni.2008.04.002 18455451
88. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. de Yebenes VG, Belver L, Pisano DG, Gonzalez S, Villasante A, Croce C, He L, Ramiro AR, The Journal of Experimental Medicine 2008 205 2199 2206 10.1084/jem.20080579 18762567
89. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, et al. The Journal of Experimental Medicine 2011 208 1189 1201 10.1084/jem.20101823 21555486
90. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK, J Virol 2008 82 1946 1958 10.1128/JVI.02136-07 18057241 (Pubitemid 351206940)
91. Signaling to NF-kappaB by Toll-like receptors. Kawai T, Akira S, Trends Mol Med 2007 13 460 469 10.1016/j.molmed.2007.09.002 18029230 (Pubitemid 350086981)
92. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, Baltimore D, Proc Natl Acad Sci USA 2011 108 9184 9189 10.1073/pnas.1105398108 21576471
93. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Gururajan M, Haga CL, Das S, Leu CM, Hodson D, Josson S, Turner M, Cooper MD, Int Immunol 2010 22 583 592 10.1093/intimm/dxq042 20497960
94. A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et al. The New England Journal of Medicine 2005 353 1793 1801 10.1056/NEJMoa050995 16251535 (Pubitemid 41549891)
95. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al. Proc Natl Acad Sci USA 2002 99 15524 15529 10.1073/pnas.242606799 12434020 (Pubitemid 35403967)
96. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM, Proceedings of the National Academy of Sciences of the United States of America 2004 101 2999 3004 10.1073/pnas.0307323101 14973191 (Pubitemid 38327724)
97. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Mi S, Li Z, Chen P, He C, Cao D, Elkahloun A, Lu J, Pelloso LA, Wunderlich M, Huang H, et al. Proc Natl Acad Sci USA 2010 107 3710 3715 10.1073/pnas.0914900107 20133587
98. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM, Proc Natl Acad Sci USA 2006 103 7024 7029 10.1073/pnas.0602266103 16641092
99. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. 99. Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, et al. Blood 2009 114 1374 1382 10.1182/blood-2009-05-220814 19520806
100. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, et al. Blood 2008 111 3183 3189 10.1182/blood-2007-07-098749 18187662
101. miR-15 and miR-16 induce apoptosis by targeting BCL2. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. Proc Natl Acad Sci USA 2005 102 13944 13949 10.1073/pnas. 0506654102 16166262 (Pubitemid 41377683)
102. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Medina PP, Nolde M, Slack FJ, Nature 2010 467 86 90 10.1038/nature09284 20693987
103. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, et al. JAMA 2011 305 59 67 10.1001/jama.2010.1919 21205967
104. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Zenz T, Mohr J, Eldering E, Kater AP, Buhler A, Kienle D, Winkler D, Durig J, van Oers MH, Mertens D, et al. Blood 2009 113 3801 3808 10.1182/blood-2008-08-172254 18941118
105. Chronic lymphocytic leukemia. Chiorazzi N, Rai KR, Ferrarini M, N Engl J Med 2005 352 804 815 10.1056/NEJMra041720 15728813 (Pubitemid 40271175)
106. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grander D, Iyengar A, Baranova A, Kashuba V, Merup M, et al. Oncogene 1997 15 2463 2473 10.1038/sj.onc.1201643 9395242 (Pubitemid 27503532)
107. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. 107. Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, et al. Blood 2001 97 2098 2104 10.1182/blood.V97.7. 2098 11264177 (Pubitemid 32239092)
108. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, Dalla-Favera R, Cancer Cell 2010 17 28 40 10.1016/j.ccr.2009.11.019 20060366
109. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, et al. International Journal of Cancer 2007 121 1156 1161 10.1002/ijc.22800 (Pubitemid 47101656)
110. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M, Cancer Res 2004 64 3087 3095 10.1158/0008-5472.CAN-03-3773 15126345 (Pubitemid 38581408)
111. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. 111. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM, Tam W, The American Journal of Pathology 2008 173 242 252 10.2353/ajpath.2008.080009 18583325 (Pubitemid 351947971)
112. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. 112. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, et al. Cancer Cell 2010 18 367 381 10.1016/j.ccr.2010. 09.005 20951946
113. MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response. Iborra M, Bernuzzi F, Invernizzi P, Danese S, Autoimmunity reviews 2010 11 305 314 20627134
114. The type I interferon system in systemic lupus erythematosus. Ronnblom L, Eloranta ML, Alm GV, Arthritis and rheumatism 2006 54 408 420 10.1002/art.21571 16447217 (Pubitemid 43228615)
115. Systemic lupus erythematosus: all roads lead to type I interferons. Pascual V, Farkas L, Banchereau J, Curr Opin Immunol 2006 18 676 682 10.1016/j.coi.2006.09.014 17011763 (Pubitemid 44635182)
116. Type I interferon in systemic lupus erythematosus. Crow MK, Current topics in microbiology and immunology 2007 316 359 386 10.1007/978-3-540-71329- 6-17 17969456
117. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, et al. Arthritis and rheumatism 2009 60 1065 1075 10.1002/art.24436 19333922
118. Regulatory T cells and Foxp3. Rudensky AY, Immunol Rev 2011 241 260 268 10.1111/j.1600-065X.2011.01018.x 21488902
119. Dicer-dependent microRNA pathway safeguards regulatory T cell function. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY, The Journal of experimental medicine 2008 205 1993 2004 10.1084/jem.20081062 18725526
120. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, Loeb GB, Lee H, Yoshimura A, Rajewsky K, Rudensky AY, Immunity 2009 30 80 91 10.1016/j.immuni.2008.11.010 19144316
121. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, Yoshimura A, Baltimore D, Rudensky AY, Cell 2010 142 914 929 10.1016/j.cell.2010.08.012 20850013
122. MicroRNAs as biomarkers in rheumatic diseases. Alevizos I, Illei GG, Nature reviews Rheumatology 2010 6 391 398 10.1038/nrrheum.2010.81 20517293
123. Silencing of microRNAs in vivo with 'antagomirs'. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M, Nature 2005 438 685 689 10.1038/nature04303 16258535 (Pubitemid 41740580)